Therapeutics

Cidara Therapeutics Announces Closing of Concurrent Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering of Common Stock

2 days ago   |   By San Diego Biotechnology

SAN DIEGO, Oct. 13, 2021 - Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced the closing of its previously announced concurrent but separate underwritten public offerings of 17,064,511 shares of...
Read more ...

 

Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2 Antibody Drug Conjugate for multiple solid tumors

2 days ago   |   By San Diego Biotechnology

SAN DIEGO, Oct. 13, 2021 - Sorrento Therapeutics, Inc. previously announced that its partner Escugen Biotechnology Co, Ltd. and Sorrento's subsidiary Levena Biopharma Co., Ltd. had received an approval letter from the Center for Drug Evaluation of the National Medical...
Read more ...

 

FDA Authorizes Sorrento Phase 2 Trial of Epidural Resiniferatoxin for the Orphan Indication of Control of Intractable Cancer Pain

2 days ago   |   By San Diego Biotechnology

SAN DIEGO, Oct. 13, 2021 - Sorrento Therapeutics, Inc. announced that the company has received FDA clearance to proceed with a global Phase 2 clinical study of resiniferatoxin , entitled “A Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Epidural Resiniferatoxin...
Read more ...

 

Progenity Announces Several Patents Granted by USPTO, Strengthening the Company's Intellectual Property Position in Ingestible Therapeutics Technologies

2 days ago   |   By San Diego Biotechnology

SAN DIEGO, Oct. 13, 2021 - Progenity, Inc. , an innovative biotechnology company, announced today that the United States Patent and Trademark Office has issued four patents related to its ingestible technologies for delivery of therapeutics via the gastrointestinal ...
Read more ...

 


Search by Tags

   Therapeutics      BioTechnology      News      Nasdaq      CDTXUS1717571079      Drugs      Clinical      BioPharma      Drug      Biopharma      SRNEUS83587F2020      Cancer      PROGUS74319F1075  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Cellular environments shape molecular architecture

An important cellular structure called the nuclear pore complex has larger dimensions than previously thought. A research team made this discovery using cryo-focused ion beam... Read more ...

Sr Scientist - Protein Sciences - Novartis / NIBR / GNF / San Diego...

High degree of self-motivation and attention to detail. Support the collection of analytical data. Present scientific and technical work.From Novartis - Sat, 16 Oct 2021... Read more ...

Benchmarking sequencing methods and tools that facilitate the study of...

Alternative cleavage and polyadenylation , an RNA processing event, occurs in over 70% of human protein-coding genes. APA results in mRNA transcripts with distinct 3′ ends... Read more ...

A global screening identifies chromatin-enriched RNA-binding proteins and...

Cellular RNA-binding proteins have multiple roles in post-transcriptional control, and some are shown to bind DNA. However, the global localization and the general... Read more ...

KrasG12D induces changes in chromatin territories that differentially impact...

Pancreatic ductal adenocarcinoma initiation is most frequently caused by Kras mutations. Read more ...

San Diego biotech veterans launch novel therapeutics firm targeting cancer...

Tentarix comes out of stealth mode, raises $50 million in venture funding led by Versant Ventures, Samsara BioCapital Read more ...

Genetic and process engineering strategies for enhanced recombinant...

The production of N-linked glycoproteins in genetically amenable bacterial hosts offers great potential for reduced cost, faster/simpler bioprocesses, greater customisation... Read more ...

Associate Director/Director Translational Research - Viracta Therapeutics...

5+ years of pharmaceutical or biotechnology industry experience in oncology/cancer immunotherapy. Viracta Therapeutics, a precision oncology company focused on...From Viracta... Read more ...

Long-Term Stable Reduction of Low-Density Lipoprotein in Nonhuman Primates...

Wang, L. et al. Molecular Therapy. 6, 2019-2029 (2021). Read more ...

Mitochondrial Targeted Meganuclease as a Platform to Eliminate Mutant mtDNA...

Zekonyte, U. et al. Nat Commun. 12, 3210 (2021). Read more ...